柏勒罗丰治疗(BLPH)

0.0571 0.0026 4.770642%

今开:0.0572昨收:0.0545
最高:0.0572 最低:0.0571
涨停价:0.0跌停价:0.0
总市值:698484.0

柏勒罗丰治疗的热门讨论

韭黄沾糖2023-06-08 21:35

$柏勒罗丰治疗(BLPH)$ 年底看到6元查看全文

当期报告

柏勒罗丰治疗(BLPH)2023-01-05 21:42

$柏勒罗丰治疗(BLPH)$ 8-K Current report, item 1.01 Accession Number: 0001600132-23-000003  Act: 34  Size: 157 KB 网页链接查看全文

当期报告

柏勒罗丰治疗(BLPH)2023-11-22 05:25

$柏勒罗丰治疗(BLPH)$ 8-K Current report, item 5.02 Accession Number: 0001104659-23-120348  Act: 34  Size: 199 KB 网页链接查看全文

季度财报

柏勒罗丰治疗(BLPH)2023-11-15 06:55

$柏勒罗丰治疗(BLPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-23-019044  Act: 34  Size: 5 MB 网页链接查看全文

股东委托书协议

柏勒罗丰治疗(BLPH)2023-11-07 05:35

$柏勒罗丰治疗(BLPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-23-114775  Act: 34  Size: 947 KB 网页链接查看全文

其他

柏勒罗丰治疗(BLPH)2023-10-27 22:55

$柏勒罗丰治疗(BLPH)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-23-112046  Act: 34  Size: 1 MB 网页链接查看全文

其他

柏勒罗丰治疗(BLPH)2023-10-17 02:05

$柏勒罗丰治疗(BLPH)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-109317  Act: 33  Size: 30 KB 网页链接查看全文

超过5%股东持股披露「修订」

柏勒罗丰治疗(BLPH)2023-10-17 18:05

$柏勒罗丰治疗(BLPH)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001760460-23-000009  Act: 34  Size: 50 KB 网页链接查看全文

当期报告

柏勒罗丰治疗(BLPH)2023-10-13 22:35

$柏勒罗丰治疗(BLPH)$ 8-K Current report, item 5.02 Accession Number: 0001104659-23-109006  Act: 34  Size: 193 KB 网页链接查看全文

其他

柏勒罗丰治疗(BLPH)2023-10-17 02:05

$柏勒罗丰治疗(BLPH)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-109313  Act: 33  Size: 30 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38

柏勒罗丰治疗的新闻

临床治疗药物公司Bellerophon(BLPH.O)盘初跳涨18%

临床治疗药物公司Bellerophon(BLPH.O)盘初跳涨18%,触及熔断。 网页链接

柏勒罗丰治疗的公告

当期报告

$柏勒罗丰治疗(BLPH)$ 8-K Current report, item 5.02 Accession Number: 0001104659-23-120348  Act: 34  Size: 199 KB 网页链接

季度财报

$柏勒罗丰治疗(BLPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-23-019044  Act: 34  Size: 5 MB 网页链接

股东委托书协议

$柏勒罗丰治疗(BLPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-23-114775  Act: 34  Size: 947 KB 网页链接

其他

$柏勒罗丰治疗(BLPH)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-23-112046  Act: 34  Size: 1 MB 网页链接

超过5%股东持股披露「修订」

$柏勒罗丰治疗(BLPH)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001760460-23-000010  Act: 34  Size: 50 KB 网页链接

超过5%股东持股披露「修订」

$柏勒罗丰治疗(BLPH)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001760460-23-000009  Act: 34  Size: 50 KB 网页链接

持股变动声明

$柏勒罗丰治疗(BLPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001760460-23-000008  Size: 10 KB 网页链接

其他

$柏勒罗丰治疗(BLPH)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-109315  Act: 33  Size: 30 KB 网页链接

其他

$柏勒罗丰治疗(BLPH)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-109316  Act: 33  Size: 30 KB 网页链接

其他

$柏勒罗丰治疗(BLPH)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-109317  Act: 33  Size: 30 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41